BioSpace News Archive

Drug Development

Palatin Technologies And King Pharmaceuticals®, Inc. Initiate Phase IIb Clinical Trial Evaluating PT-141 In Patients Suffering From Female Sexual Arousal Disorder

February 7, 2006
·
6 min read
Drug Development

New River Pharmaceuticals Inc. Provides Clinical Test Results On NRP290 And Receives $50 Million Payment From Shire Pharmaceuticals

February 7, 2006
·
4 min read
Drug Development

Optimer Pharmaceuticals, Inc.'s Lead Antibiotic Candidate Moves Into Phase 2B/3 Clinical Trials For The Treatment Of Clostridium Difficile-Associated Diarrhea (CDAD)

February 7, 2006
·
3 min read
BioMidwest

Eli Lilly and Company Launches Humalog(R) Mix50/50(TM) Insulin In United States

February 7, 2006
·
3 min read
Drug Development

DOV Pharmaceutical Announces Initiation Of Phase II Clinical Trial In Osteoarthritis

February 7, 2006
·
5 min read
Drug Development

Avalon Pharmaceuticals Completes First Dosing Cycle On First Patient And Initiates Second Cohort Of AVN944 Phase I Clinical Trial In Cancer

February 7, 2006
·
4 min read
Policy

Emisphere Technologies, Inc. Responds To Eli Lilly and Company Motion

February 7, 2006
·
3 min read
Oncolytics Biotech Inc. Announces Issuance Of 14th U.S. Patent

February 7, 2006
·
3 min read
Business

Idenix Pharmaceuticals, Inc. And Novartis Corporation Seek European Approval Of Telbivudine For The Treatment Of Patients With Chronic Hepatitis B

February 7, 2006
·
7 min read
Business

Boston Scientific Corporation Announces Results For Year And Fourth Quarter Ended December 31, 2005

February 7, 2006
·
17 min read